Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Nancy Rizza

Physician Assistant, Medical South Windsor, CT Physician Assistant

NPI 1609362847 CMS profile 10697313

1504 Sullivan Ave, South Windsor, CT 06074

Open in the dashboard

General payments

$7,010

391 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Nancy Rizza of South Windsor, CT is reported in the CMS Open Payments database as having received $7,010 across 391 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $151 3
2023 General $658 32
2022 General $3,885 214
2021 General $2,316 142

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nancy Rizza
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Nancy Rizza were reported at $0. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Nancy Rizza Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $2,316 $156 $41–$563 $132
2022 $3,885 $185 $55–$649 $149
2023 $658 $199 $58–$717 $160
2024 $151 $206 $62–$740 $164
2025 $0 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Amgen Inc. $1,380 90 payments
  2. AbbVie, Inc. $1,225 67 payments
  3. AstraZeneca Pharmaceuticals LP $689 34 payments
  4. UCB, Inc. $635 36 payments
  5. Janssen Biotech, Inc. $592 36 payments
  6. Mallinckrodt Hospital Products Inc. $421 21 payments
  7. Pfizer Inc. $339 20 payments
  8. Horizon Therapeutics plc $303 21 payments
  9. GlaxoSmithKline, LLC. $238 11 payments
  10. Lilly USA, LLC $219 11 payments
  11. Other $968 44 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $6,939 389 payments
  2. Education $71 2 payments
Products named General payments · program years 2021–2024
  1. RINVOQ $1,002 55 payments
  2. SAPHNELO $689 34 payments
  3. Enbrel $652 44 payments
  4. Cimzia $635 36 payments
  5. SIMPONI ARIA $462 29 payments
  6. STELARA $462 29 payments
  7. Otezla $427 26 payments
  8. ACTHAR $421 21 payments
  9. EVENITY $375 25 payments
  10. Prolia $375 25 payments
  11. Other $4,056 228 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

69

Median for Physician Assistant: 241

Drug cost

$639

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Escitalopram Oxalate Generic 31 $314
Trazodone Hcl Generic 26 $284
Sertraline Hcl Generic 12 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$147,958

Medicare's payments for the services billed

Medicare patients

344

Average age 81

Services billed

1,967

213 women, 131 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Arthritis 58%
Alzheimer's or dementia 56%
Heart failure 39%
Atrial fibrillation 38%
Ischemic heart disease 37%
Diabetes 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUPLAZID
  • ACADIA Pharmaceuticals Inc $110
$110 — —
INGREZZA
  • Neurocrine Biosciences, Inc. $41
$41 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

391 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record